Orbicular Pharma raises $20-M from Tata Capital Healthcare Fund

Tata Capital Healthcare Fund (via Tata Capital Healthcare Fund II or TCHF II), a healthcare-focused private equity fund, has invested USD 20 million in Hyderabad-based Orbicular Pharmaceutical Technologies .Ambit acted as the exclusive financial advisor to Orbicular and its shareholders on this transaction.Orbicular specialises in developing complex generics for global markets.